The collaborators aim to show that Cytox' VariaTect SNP profiling array and an associated algorithm can effectively predict the presence of Alzheimer's pathology.
The British company has announced the results of two studies showcasing the ability of its EpiSwitch platform to diagnose and stage breast cancer and ALS patients.
The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.
The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.
NEW YORK (GenomeWeb) – Horizon Discovery Group today announced it and life sciences measurement and testing firm LGC have received a £360,224 ($612,000) research grant to develop novel reference standard materials for clinical diagnostics.
NEW YORK (GenomeWeb News) – The UK government and economic development organizations in Scotland and Northern Ireland plan to invest up to £2.8 million ($4.6 million) to fund small businesses pursuing feasibility research projects, including those involving various omics and bioinformatics techno
NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.
